BioMarin Pharmaceutical has struck a deal to purchase fellow biotechnology firm Amicus Therapeutics for about $4.8 billion in money.
Source link
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
Related Posts
Sen. Rand Paul calls Trump stake in Intel ‘a step towards socialism’
Sen. Rand Paul, R-Ky., on Wednesday criticized the Trump administration’s decision to take a 10% stake in embattled chipmaker Intel, calling the investment…
The Chinese Billionaires Having Dozens of U.S.-Born Babies Via Surrogate
Videogame government Xu Bo, mentioned to have greater than 100 kids, and different elites are constructing mega-families—testing citizenship legal guidelines…
Europe at ‘fork in the road’ between AI competition and climate
Europe stands at a crossroads: compete meaningfully within the AI race or follow its world-leading local weather objectives. “It is…